Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry. Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues. The combined company has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation in 2013, Advanced Scientifics and Alfa Aesar, both in 2015; Affymetrix and MTI-GlobalStem, both in 2016; FEI Company, Finesse Solutions, Core Informatics, and Patheon, all in 2017; Becton, Dickinson's Advanced Bioprocessing business in 2018; and Brammer Bio in 2019. As of 2017, the company had revenues of $21 billion and was a Fortune 500 company. As of 2018, the company employed on the order of 70,000 workers, and was reporting $US 24 billion in annual revenues. In March 2020, Thermo Fisher received emergency use authorization from the FDA for a test for SARS-CoV-2 to help mitigate the COVID-19 pandemic.